Tivic Health Systems Inc.
(TIVC)
undefined
undefined%
At close: undefined
0.22
0.27%
After-hours Dec 13, 2024, 05:18 PM EST
Company Description
Tivic Health Systems Inc. operates as a bioelectronic device company that delivers non-invasive neuromodulation products for the treatment of inflammatory conditions.
Its primary product is ClearUP, is a medical device intended to relieve sinus and nasal inflammation.
The company sells its products on direct-to-consumer channel through its own websites; and platforms, such as Amazon.com and Walmart.com, as well as to U.S. online retailers, including BestBuy.com and FSAStore.com.
Tivic Health Systems, Inc. was incorporated in 2016 and is headquartered in Hayward, California.
Tivic Health Systems Inc.
| Country | United States |
| IPO Date | Nov 11, 2021 |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Employees | 9 |
| CEO | Jennifer Ernst |
Contact Details
Address: 25821 Industrial Boulevard Hayward, California United States | |
| Website | https://www.tivichealth.com |
Stock Details
| Ticker Symbol | TIVC |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001787740 |
| CUSIP Number | 888705100 |
| ISIN Number | US8887052095 |
| Employer ID | 81-4016391 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Jennifer Ernst | Co-Founder, Chief Executive Officer & Director |
| Lisa G. Wolf | Interim Chief Financial Officer |
| Dr. Blake Gurfein Ph.D. | Chief Scientific Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 14, 2024 | 10-Q | Quarterly Report |
| Nov 14, 2024 | 8-K | Current Report |
| Nov 07, 2024 | 1-A/A | [Amend] Filing |
| Oct 04, 2024 | 1-A/A | [Amend] Filing |
| Oct 03, 2024 | 4 | Filing |
| Oct 03, 2024 | 4 | Filing |
| Oct 03, 2024 | 3 | Filing |
| Sep 18, 2024 | 8-K | Current Report |
| Sep 17, 2024 | 8-K | Current Report |
| Sep 13, 2024 | 8-K | Current Report |